Log In
BCIQ
Print this Print this
 

DM-199

  Manage Alerts
Collapse Summary General Information
Company DiaMedica Inc.
DescriptionRecombinant human tissue kallikrein-1 protein (rhKLK-1)
Molecular Target Kallikrein 1 (KLK1)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today